New therapeutic strategy for intractable respiratory diseases through CD26/DPP-4
New therapeutic strategy for intractable respiratory diseases through CD26/DPP-4
批准号:
19K17663
负责人:
Kawasaki Takeshi
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Early-Career Scientists
财政年份:
2019
资助国家:
日本
项目状态:
已结题
起止时间:
2019-04-01 至 2022-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Potential Functional Roles for CD26/Dipeptidyl Peptidase-4 in Mediating Responses of Human Lung Microvascular Endothelial Cells
CD26/二肽基肽酶 4 在介导人肺微血管内皮细胞反应中的潜在功能作用
DOI:
--
发表时间:
2022
期刊:
影响因子:
--
作者:
[Yukiko Takahashi, Takeshi Kawasaki, Hironori Sato, Yoshinori Hasegawa, Steven M. Dudek, Osamu Ohara, Koichiro Tatsumi, and Takuji Suzuki]
通讯作者:
and Takuji Suzuki
Alleviation of mouse LPS-induced lung injury by CD26/DPP4 deficiency
CD26/DPP4 缺乏减轻小鼠 LPS 诱导的肺损伤
DOI:
--
发表时间:
2021
期刊:
影响因子:
--
作者:
[Syun Sato, Takeshi Kawasaki, Ryo Hatano, Yu Koyanagi, Yukiko Takahashi, Seiichiro Sakao, Kei Ohnuma, Chikao Morimoto, Steven M. Dudek, Koichiro Tatsumi, Takuji Suzuki]
通讯作者:
Takuji Suzuki
LPS-induced lung injury is attenuated in CD26/DPP4 deficient mice
CD26/DPP4 缺陷小鼠中 LPS 诱导的肺损伤减轻
DOI:
--
发表时间:
2021
期刊:
影响因子:
--
作者:
[Syun Sato, Takeshi Kawasaki, Ryo Hatano, Yu Koyanagi, Yukiko Takahashi, Seiichiro Sakao, Kei Ohnuma, Chikao Morimoto, Steven M. Dudek, Koichiro Tatsumi]
通讯作者:
Koichiro Tatsumi
Inhibition of CD26/Dipeptidyl Peptidase-4 Expression Causes Anti-Inflammatory and Pro-Proliferative Effects in Human Lung Microvascular Endothelial Cells
抑制 CD26/二肽基肽酶 4 表达可在人肺微血管内皮细胞中产生抗炎和促增殖作用
DOI:
--
发表时间:
2021
期刊:
影响因子:
--
作者:
[Y. Takahashi, T. Kawasaki, S. Sato, K. Yu, S. M. Dudek, K. Tatsumi]
通讯作者:
K. Tatsumi
Unified understanding of the mechanical response of solids by energy landscape and non-equilibrium phase transition picture
-
批准号:19K03767
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.66万
-
财政年份:2019
-
负责人:Kawasaki Takeshi
-
依托单位:
海外基金